Genomic landscape and clinical characteristics of patients (pts) with neuroendocrine prostate cancer (NEPC) with or without aggressive variant prostate cancer characterized by molecular signature (AVPC-MS).

Hedyeh Ebrahimi, Alex Chehrazi‐Raffle, Miguel Zugman et al.|Journal of Clinical Oncology|2025

Cited by 1